BDBM50200884 3-(2-(benzylamino)-3,4-dioxocyclobut-1-enylamino)-2-hydroxy-N,N-dimethylbenzamide::CHEMBL385784
SMILES: CN(C)C(=O)c1cccc(Nc2c(NCc3ccccc3)c(=O)c2=O)c1O
InChI Key: InChIKey=HATZRSBFZYTSOM-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
C-X-C chemokine receptor type 2 (Homo sapiens (Human)) | BDBM50200884 (3-(2-(benzylamino)-3,4-dioxocyclobut-1-enylamino)-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | 236 | n/a | n/a | n/a | n/a | n/a | n/a |
Schering-Plough Research Institute Curated by ChEMBL | Assay Description Displacement of [125I]hCXCL8 from human CXCR2 receptor expressed in BaF3 cells | J Med Chem 49: 7603-6 (2006) Article DOI: 10.1021/jm0609622 BindingDB Entry DOI: 10.7270/Q2KW5GVR | |||||||||||
More data for this Ligand-Target Pair |